Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.

Wang PP, Xu DJ, Huang C, Wang WP, Xu WK.

Mol Med Rep. 2014 Jun;9(6):2131-7. doi: 10.3892/mmr.2014.2074. Epub 2014 Mar 27.

2.

Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II.

Huang C, Xu D, Xia Q, Wang P, Rong C, Su Y.

J Pharm Pharmacol. 2012 Dec;64(12):1741-50. doi: 10.1111/j.2042-7158.2012.01549.x. Epub 2012 Jun 8.

PMID:
23146037
3.

The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.

Yuan F, Liu J, Qiao T, Li T, Shen Q, Peng F.

Molecules. 2016 Jun 28;21(7). pii: E852. doi: 10.3390/molecules21070852.

4.

Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.

Gu W, Fang FF, Li B, Cheng BB, Ling CQ.

Asian Pac J Cancer Prev. 2012;13(9):4807-14.

5.

Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.

Shi LX, Ma R, Lu R, Xu Q, Zhu ZF, Wang L, Zhou CL, Li XL, Zhang HL, Yao Z.

Cancer Lett. 2008 Sep 28;269(1):101-10. doi: 10.1016/j.canlet.2008.04.033. Epub 2008 Jun 5.

PMID:
18538471
7.

[Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].

Wei L, Su N, Zheng DY, Cao MR, Li AM, Yan X, Lü CW, Luo RC.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Apr;25(4):344-7. Chinese.

PMID:
19351508
8.

Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.

Gu W, Liu L, Fang FF, Huang F, Cheng BB, Li B.

Oncol Rep. 2014 Jan;31(1):216-22. doi: 10.3892/or.2013.2817. Epub 2013 Oct 24.

PMID:
24173654
9.

TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.

Lu F, Hou YQ, Song Y, Yuan ZJ.

Anat Rec (Hoboken). 2013 Jan;296(1):56-63. doi: 10.1002/ar.22611. Epub 2012 Nov 4.

10.

MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.

Chen Z, Ma T, Huang C, Zhang L, Lv X, Xu T, Hu T, Li J.

Cell Signal. 2013 Dec;25(12):2693-701. doi: 10.1016/j.cellsig.2013.08.032. Epub 2013 Sep 7.

PMID:
24018051
11.

Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.

Zhang Y, Liu G, Lin C, Liao G, Tang B.

Life Sci. 2013 May 20;92(17-19):896-902. doi: 10.1016/j.lfs.2013.03.010. Epub 2013 Apr 3.

PMID:
23562851
12.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
13.

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.

Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.

Toxicol In Vitro. 2010 Sep;24(6):1474-81. doi: 10.1016/j.tiv.2010.07.020. Epub 2010 Jul 23.

PMID:
20656007
14.

Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.

Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.

Cancer Chemother Pharmacol. 2002 May;49(5):391-7. Epub 2002 Feb 14.

PMID:
11976833
15.

Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro.

Tian QE, De Li H, Yan M, Cai HL, Tan QY, Zhang WY.

BMC Complement Altern Med. 2012 Jul 11;12:94. doi: 10.1186/1472-6882-12-94.

16.

Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.

Liu B, Staren ED, Iwamura T, Appert HE, Howard JM.

J Surg Res. 2001 Aug;99(2):179-86.

PMID:
11469885
17.

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.

Gao A, Wang X, Xiang W, Liang H, Gao J, Yan Y.

J Pharm Pharmacol. 2010 Mar;62(3):393-9. doi: 10.1211/jpp.62.03.0016.

PMID:
20487225
18.

Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.

Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z.

Pharm Biol. 2013 Sep;51(9):1196-203. doi: 10.3109/13880209.2013.784342. Epub 2013 Jun 19.

PMID:
23777360
19.

siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.

Yang H, Ding R, Tong Z, Huang J, Shen L, Sun YU, Liao J, Yang Z, Hoffman RM, Wang C, Meng X.

Anticancer Res. 2016 Jun;36(6):2675-82.

PMID:
27272776
20.

[Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].

Gai XD, Li GL, Huang JZ, Xue HJ, Wang D.

Ai Zheng. 2006 Aug;25(8):954-9. Chinese.

PMID:
16965674

Supplemental Content

Support Center